| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.87B | 2.81B | 2.57B | 2.31B | 1.98B |
| Gross Profit | 1.04B | 1.03B | 925.68M | 817.26M | 667.65M |
| EBITDA | 299.21M | 529.24M | 308.62M | 433.02M | 335.58M |
| Net Income | 219.73M | 247.52M | 224.45M | 201.00M | 109.80M |
Balance Sheet | |||||
| Total Assets | 1.09B | 1.07B | 983.28M | 937.63M | 900.15M |
| Cash, Cash Equivalents and Short-Term Investments | 173.13M | 159.51M | 165.15M | 146.05M | 130.08M |
| Total Debt | 342.94M | 328.15M | 324.96M | 324.14M | 323.65M |
| Total Liabilities | 550.77M | 533.42M | 526.91M | 458.92M | 462.11M |
| Stockholders Equity | 542.58M | 534.56M | 456.37M | 478.71M | 438.04M |
Cash Flow | |||||
| Free Cash Flow | 450.38M | 401.32M | 422.16M | 332.58M | 272.88M |
| Operating Cash Flow | 461.07M | 416.74M | 448.94M | 361.66M | 298.59M |
| Investing Cash Flow | -8.70M | -9.57M | -20.17M | -29.30M | -26.47M |
| Financing Cash Flow | -438.85M | -378.54M | -325.18M | -316.18M | -233.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$780.07M | 3.97 | 9.79% | 6.83% | 3.55% | 8.38% | |
68 Neutral | HK$1.71B | 9.28 | 21.25% | 10.34% | 2.23% | -11.23% | |
67 Neutral | HK$2.18B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
63 Neutral | HK$2.17B | 1.51 | 15.14% | 12.14% | -0.95% | 2.58% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$2.70B | 9.26 | 8.16% | 4.75% | -3.18% | -36.46% | |
58 Neutral | HK$1.74B | 18.39 | 1.63% | 2.14% | -20.02% | 10.62% |